The first of over 1,000 Zoloft birth defect lawsuits has gone to trial, and a lawyer has provided evidence that Pfizer researchers concluded that women who take Zoloft while pregnant risk giving birth to children with heart defects. According to Bloomberg, the evidence is contained in a May 2014 internal report on Zoloft, in which the babies of women taking the drug were found to be ...
Pfizer Accused of Knowing Zoloft Posed Risk of Birth Defects
Posted May 10, 2015 in Product News and Recalls
Pfizer CEO’s Pay Rises 23%
Posted April 7, 2015 in Product News and Recalls
Pfizer Chief Executive Ian Read’s total pay rose 23 percent last year, a Wall Street Journal article reports. Read’s total pay package for 2014 was $23.3 million. The pay increase comes after Pfizer’s board declared Read’s leadership last year to be “outstanding.”
Despite the board’s praise, 2014 was hardly a trouble-free year for the New York–based company. As in previous years, Lipitor lawsuits continued to accumulate against Pfizer. ...
continue reading...4 Things You Absolutely Need to Know About Lipitor Lawsuits
Posted March 27, 2015 in Lipitor | Product News and Recalls
As evidence continues to mount proving Lipitor’s role in causing Type II diabetes in women, questions continue to surface about how to file a Lipitor lawsuit.
The cholesterol-reduction drug has been on the market since 1996 and millions of prescriptions have been written each year since. It wasn’t until 2012, however, that the Food and Drug Administration began raising alarms about a possible link between Lipitor and diabetes, particularly among female patients.
There ...
continue reading...Lipitor Lawsuits Continue to Accumulate Against Pfizer
Posted February 27, 2015 in Lipitor | Product News and Recalls
The number of Lipitor lawsuits against the pharmaceutical company Pfizer continues to grow. A story in Reuters explains the rising number of diabetes lawsuits that allege the anti-cholesterol drug has caused serious health complications in women. The number of lawsuits filed over the past five months in federal court has gone from 56 to almost 1,000.
In 2012 the FDA issued a warning that statins such as Lipitor have been linked to an increase in blood ...
continue reading...FDA Advises Leaving Black Box Warning on Pfizer’s Chantix
Posted December 19, 2014 in Product News and Recalls
The United States Food and Drug Administration decided to maintain the black box warning on Pfizer’s smoking cessation drug Chantix (varenicline). The drug continues to carry the very serious black box warning which was first added to the label in 2009.
In seeking the removal of the black box warning, Pfizer relied on a meta-analysis of five studies to argue there is no association between the drug and suicidal thoughts. The advisory panel nonetheless is ...
continue reading...Pfizer’s Illegal Drug Marketing Charges Settle for $35 million
Posted November 17, 2014 in Drug and Medical Device Lawsuits | Product News and Recalls | Verdicts & Settlements
Wyeth Pharmaceuticals, a subsidiary of Pfizer, was charged with illegally marketing a drug that was not cleared for use by the FDA. A story in Reuters reports that Wyeth illegally marketed its organ transplant drug Rapamune for conditions it was not approved to treat.
The charges indicated that Wyeth trained and encouraged sales representatives to promote Rapamune for uses other than preventing rejection ...
continue reading...
